Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Kevin Gurney, Ph.D. (he/him/his)
Merck & Co., Inc.
Poster(s):
(M1130-09-56) Development of an Industry Ready Cell-Based Potency Method for an Oncolytic Virus Immunotherapy
Monday, October 23, 2023
11:30 AM – 12:30 PM
ET